- Home
- SVA
as 12-20-2024 4:00pm EST
Stocks
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
| Founded: | N/A | Country: | N/A |
| Employees: | 3261 | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest SINOVAC BIOTECH LTD News
SVA Breaking Stock News: Dive into SVA Ticker-Specific Updates for Smart Investing
Business Wire
6 days ago
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
Simply Wall St.
a month ago
Undervalued Small Caps With Insider Action On TSX In November 2024
Business Wire
4 months ago
SINOVAC Reports Unaudited First Half of 2024 Financial Results
Business Wire
8 months ago
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Zacks
a year ago
Here's Why Arch Capital Group (ACGL) is a Strong Momentum Stock
Business Wire
a year ago
Edgio Names BDO as Independent Auditor
InvestorPlace
a year ago
The Housing Hiccup: 3 Stocks to Sell as the Real Estate Market Cools
ACCESSWIRE
a year ago
Camber Energy Announces Agreement with Distributor for VKIN-Ozone Proprietary Waste Treatment System
Compare SVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SVA SINOVAC BIOTECH LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.